Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Danske Invest-Bioteknologi Fund

+ Add to Watchlist

DANIBIO:DC

322.5000 DKK 0.1000 0.03%

As of 11:20:00 ET on 02/27/2015.

Snapshot for Danske Invest-Bioteknologi Fund (DANIBIO)

Open: 323.3000 High - Low: 328.4000 - 322.3000 Primary Exchange: Copenhagen
Volume: 30,203 52-Week Range: 164.1000 - 328.4000 Beta vs BTK: 0.9526

ETF Chart for DANIBIO

No chart data available.
  • DANIBIO:DC 322.5000
  • 1D
  • 1M
  • 1Y
322.6000
Interactive DANIBIO Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for DANIBIO

Danske Invest Bioteknologi Fund is an open-end fund registered in Denmark. The Fund's objective is capital appreciation, and to outperform NASDAQ's biotech-index(NBI). The Fund invests worldwide in equity of biotechnology companies, and companies closely related to the biotechnology sector.

Inception Date: 2000-05-26 Telephone: 45-3333-7171
Managers: -
Web Site: www.danskeinvest.dk

Fundamentals for DANIBIO

NAV (on 2015-02-27) 318.4100
Assets (M) (on 2015-01-30) 1,180.7610
Shares out (M) 0.00
Market Cap (M) 0.00
% Premium 1.28
Average 52-Week % Premium 0.9793
Fund Leveraged N

Dividends for DANIBIO

Dividend Type Income
Dividend Frequency Annual
Last Dividend Net (on 2014-04-25) 12.8000
Dividend Yield (ttm) 3.97%

Performance for DANIBIO

1-Month +4.77% 1-Year +60.23%
3-Month +26.36% 3-Year +49.25%
Year To Date +20.60% 5-Year +33.24%
Expense Ratio 1.50

Top Fund Holdings for DANIBIO

Filing Date: 12/31/2014
Name Position Value % of Total
Isis Pharmaceuticals Inc 109,980 41,784,979 4.466%
Cubist Pharmaceuticals Inc 66,560 41,225,596 4.407%
Incyte Corp 87,570 39,397,801 4.211%
NPS Pharmaceuticals Inc 167,588 36,889,410 3.943%
Alkermes PLC 101,758 36,669,879 3.920%
BioMarin Pharmaceutical Inc 62,236 34,621,825 3.701%
Celgene Corp 49,753 34,247,899 3.661%
Nektar Therapeutics 353,627 33,730,048 3.605%
Amgen Inc 32,823 32,174,117 3.439%
Cepheid 94,390 31,447,352 3.361%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil